ARO-HSD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ARO-HSD, covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH [Phase 1, Phase 2]